Concurrent Technologies Posts Record FY24 Results with 40% Profit Surge and Strategic Expansion
Concurrent Tech's FY24: £5.2m pre-tax profit (+40%), £40.3m revenue (+27%), defence dominance & US expansion fuel record growth.
This article covers information on Concurrent Technologies PLC.
LON:CNCCracking the Code: Concurrent Technologies’ Stellar FY24 Performance
If you’ve been tracking UK tech stocks, you’ll know that Concurrent Technologies (AIM: CNC) has been quietly building momentum like a Rolls-Royce engine. Today’s FY24 results aren’t just good-they’re the sort of numbers that make you sit up and recalibrate your watchlist. Let’s unpack why this embedded computing specialist is suddenly looking like a heavyweight contender.
The Numbers That Matter
First, the headline acts:
- Revenue surge: £40.3m (up 27% YoY) – smashing through the £30m barrier
- Profit before tax: £5.2m (40% jump) – and that’s after £1.1m strategic investment in Systems
- Order intake: £41m (45% growth) – future revenue visibility looking crisp
- Cash pile: £13.7m (23% increase) – war chest status: loaded
| Metric | 2024 | 2023 | Growth |
|---|---|---|---|
| Revenue | £40.3m | £31.7m | +27% |
| Gross Margin | 49.5% | 48.4% | +110bps |
| EBITDA | £7.8m | £6.0m | +30% |
Where the Magic Happened
1. Products Division: The Cash Cow Gets Hungrier
The core boards business delivered 22 design wins, including a landmark $6m US defence contract-their largest ever. With defence now accounting for 87% of board revenue, Concurrent’s VME and SOSA-aligned tech is becoming the backbone of military upgrades worldwide.
2. Systems Division: From Embryo to Contender
Last year’s £1.1m investment in Systems is paying dividends:
- Phillips Aerospace fully integrated
- $3.7m Asian defence contract secured
- Team doubled in key US markets
This isn’t just diversification-it’s building a second growth engine.
The Secret Sauce
Three strategic masterstrokes stand out:
- R&D Cadence: New launches like Rhea (VME support) and Hermod II (rugged Ethernet switches) show serious innovation chops
- Geopolitical Positioning: 45% of revenue now from US markets-a smart hedge against European volatility
- Cultural Reshape: CEO Miles Adcock’s “no spectators” ethos is clearly translating to execution speed
Looking Down the Sights
The roadmap suggests this is just the warm-up act:
- Capacity expansion: New 20-year Colchester lease + planned US manufacturing
- Pipeline: £100m+ lifetime value from major design wins
- OTCQX listing: Smart play for stateside investor attention
Yes, there are clouds-US tariff uncertainties loom large. But with 45% order growth and a £13.7m cash buffer, Concurrent looks armed to navigate turbulence.
The Bottom Line
This isn’t just a good year-it’s validation of a multi-year transformation. When a niche player starts delivering 40% profit growth while funding new divisions and maintaining 49.5% margins, you’re looking at exceptional operational discipline. The £100m revenue target suddenly feels like a waypoint rather than a destination.
For investors? The 10% dividend hike says confidence. The order book says visibility. The Systems buildout says optionality. In a world hungry for defence tech and rugged computing, Concurrent’s FY24 numbers suggest they’re just starting to flex their muscles.
Related
Keep reading
Investing
Maruwa annual results: sales rise but profits slip as investment surges
Maruwa delivered higher sales and a stronger order book, but lower profit and heavy investment weighed on annual cash flow.
JoshuaJuly 31, 2026
Investing
Wellnex Life Q4 FY26: Cash Flow Positive Again, but Funding Remains Tight
Wellnex Life ended FY26 with stronger revenue, positive quarterly operating cash flow and $862,000 in cash, but financing remains important.
JoshuaJuly 31, 2026
Investing
Ferro-Alloy raises £5.7 million at 25.3% discount to repay Kazakh bonds
Ferro-Alloy has raised £5.7 million at a 25.3% discount, providing funds for bond repayment but creating substantial shareholder dilution.
JoshuaJuly 31, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.